Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SA-504

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
The effect of the antispasmodic agent, SA-504 subtle granules, was studied. Ninety mg per day of timepidium bromide subtle… Expand
Is this relevant?
1977
1977
The colored substances excreted in bile or urine have bee investigated after adminstration of a high dose of SQ-504 to rats. A… Expand
Is this relevant?
1976
1976
Relationship between pharmacological activities and blood levels of a new anticholinergic agent (SA-504), as well as excretion… Expand
Is this relevant?
1973
1973
Effects of 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504) on the motility of gastrointestinal… Expand
Is this relevant?
1973
1973
An influence of a new antispasmodica, SA-504, 1, 1-Dimethy1-5-methoxy-3-(dithiene-2-ylmethylene)-piperidinium bromide upon the… Expand
Is this relevant?
1972
1972
In the course of screening anticholinergic agents, tipepidine hibenzoate (Asverin®), a piperidine derivative with a tertiary… Expand
Is this relevant?